The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a lung carcinogen in rats and may be a cause of lung cancer in smokers. NNK is metabolized by cytochromes P450 to intermediates that react with DNA forming methyl, pyridyloxobutyl (POB), and pyridylhydroxybutyl (PHB) adducts, which are critical in carcinogenesis. The methyl adduct 
Lung cancer is the leading cause of cancer death in the world, killing approximately 3000 people every day (International Agency for Research on Cancer, 2004) . Cigarette smoking causes approximately 90% of lung cancer (International Agency for Research on Cancer, 2004) . Although there are multiple pulmonary carcinogens in cigarette smoke, one of the most potent in animal models is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (Hecht, 1998 (Hecht, , 2008 . NNK induces adenoma and adenocarcinoma of the lung in rats, mice, hamsters, and ferrets, independent of the route of administration (Hecht, 1998) . It is particularly effective in the rat, in which chronic treatment with 1 ppm in the drinking water for 2 years caused a significant incidence of lung tumors (Rivenson et al., 1988) .
The major mechanism by which NNK initiates the carcinogenic process is cytochrome P450 (P450)-mediated ␣-hydroxylation to give intermediates 1 and 2 ( Fig. 1) (Hecht, 1998) . Multiple P450s including rat P450 2A3, human P450 2A13, mouse P450 2A5, and others are involved in this process, which results in the formation of pyridyloxobutyl (POB)-DNA adducts from intermediate 3 and methyl-DNA adducts from intermediate 4 (Jalas et al., 2005; Hecht, 2008) . Similar pathways act upon the NNK metabolite NNAL to produce pyridylhydroxybutyl (PHB)-DNA adducts as well as methyl adducts (Upadhyaya et al., 2008) . The POB-DNA adducts are O 6 -[4-(3-pyridyl)-4-oxobut-1-yl]-2Ј-deoxyguanosine (
[7-POB-dG and O 2 -POB-dC have been quantified as the corresponding bases 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine (7-POB-G) and
The PHB-DNA adducts are the corresponding carbonyl-reduced forms, and the methyl-DNA adducts are O 6 -methylguanine (O 6 -methyl-G), 7-methyl-G, and
6 -POB-dG, and O 2 -POB-T are known to have miscoding properties (Loechler et al., 1984; Altshuler et al., 1996; Delaney and Essigmann, 2001; Pauly et al., 2002; Sharma et al., 2008) . Although the DNA pyridyloxobutylation and methylation pathways of NNK metabolic activation have been well characterized for years, only ABBREVIATIONS: NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; P450, cytochrome P450; POB, pyridyloxobutyl; NNAL, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; PHB, pyridylhydroxybutyl;
-methylthymidine; LC-ESI-MS/MS-SRM, liquid chromatography-electrospray ionization-tandem mass spectrometryselected reaction monitoring; MS, mass spectrometry; AGT, O 6 recently has it become possible to quantify individual POB-DNA and PHB-DNA adducts of NNK. In previous studies, we have demonstrated the formation and persistence of individual POB-DNA and PHB-DNA adducts in the lung and liver of rats treated for 20 weeks with 10 ppm NNK in the drinking water (Lao et al., 2007; Upadhyaya et al., 2008) . In the study reported here, we quantified O 6 -methyl-G in the lung and liver of these rats and compared the levels of this mutagenic DNA adduct with those of the POB-and PHB-DNA adducts previously reported. Although O 6 -methyl-G has been measured previously in tissues of rats treated with NNK by injection (Hecht, 1998) , there are no reports in the literature of its levels in tissues of animals treated chronically with NNK in the drinking water. 6 -methyl-G (29.6 fmol/l) was prepared as an internal standard.
Materials and Methods

Chemicals
Animal Experiment. Liver and lung tissues analyzed in this study were those produced in a previous study in which rats were treated with NNK (Lao et al., 2007) . In brief, the rats were randomly divided into two groups of 54 rats and treated with either NNK (10 ppm in the drinking water) or nothing. Aqueous solutions of the carcinogen were prepared weekly and stored at 4°C, conditions under which NNK is known to be stable. The NNK solution was placed in the plastic water bottles of the rat cages twice weekly. Three rats per group were sacrificed by CO 2 overdose at 1, 2, 5, 10, 16, and 20 weeks. Tissues were harvested and stored at Ϫ80°C until DNA isolation. Sandercock et al. (2008) and Mijal et al. (2004) , we quantified O 6 -methyl-G instead of O 6 -methyl-dG. DNA was isolated from the liver and lung of three rats per group as described previously (Lao et al., 2007) . In brief, 0.05 to 1 mg of each DNA sample plus [CD 3 ]O 6 -methyl-G internal standard (20 l, 592 fmol) was dissolved in 1 ml of HCl (0.1 N) and heated at 80°C for 30 min, cooled, and neutralized with 1 N NaOH to pH 7.0. A portion of the hydrolysate (50 l) was reserved for the determination of guanine concentration. The remainder was applied to a solid-phase extraction cartridge (Strata-X; Phenomenex, Torrance, CA). The cartridge was sequentially eluted with 1 ml of H 2 O, 1 ml of methanol (10%), and 2 ml of methanol (100%). The adduct eluted in the 100% methanol fraction, which was collected and concentrated to dryness under reduced pressure using a SpeedVac (Thermo Fisher Scientific, Waltham, MA) with no heating. The resulting sample was dissolved in 20 l of NH 4 OAc (2%) for analysis by capillary LC/ESI-MS/MS-SRM on a TSQ Quantum Discovery Max instrument (Thermo Fisher Scientific) in the positive ion mode with N 2 as the nebulizing and drying gas. Mass spectrometry (MS) parameters were set as follows: spray voltage, 4 kV; sheath gas pressure, 20; capillary temperature, 250°C; collision energy, 20 V; scan width, 0.7 amu; Q2 gas pressure, 0.7 mTorr; source CID, 5 V; and tube lens offset, 90 V. Tandem mass spectrometry data were acquired and processed by Xcalibur software version 1.4 (Thermo Electron). Eight microliters of the sample was injected on a 250 ϫ 0.5 mm, 4 m Synergi C18 column (Phenomenex). The column was isocratically eluted with 88% NH 4 OAc (25 mM) and a 12% mixture of methanol and acetonitrile (75:25) at a flow rate of 12 l/min. The column was operated at 40°C. The first 5 min of eluant was directed to waste, and the 5 to 22 min fraction was diverted to the electrospray ionization source. The mass transitions (parent to daughter) monitored were 166.093149.09 for O 6 -methyl-G and 169.113152.12 for [CD 3 ]O 6 -methyl-G. Quantitation was accomplished by comparing the MS peak area ratio of the adduct with that of the deuterated standard with a calibration curve. Calibration standards were prepared by mixing various quantities of the adduct with a constant amount of the internal standard in 2% NH 4 OAc. These standards were analyzed by LC-ESI-MS/MS-SRM without undergoing the sample preparation described above. Calibration curves were made by plotting the concentration ratio (adduct: internal standard) versus the MS peak area ratio (adduct: internal standard). The amount of G in each sample was determined by high-performance liquid chromatography, and adduct levels (mean Ϯ S.D. of 3 liver or lung DNA samples per group, each analyzed once) were expressed as femtomole per milligram DNA.
Quantitation of O 6 -Methyl-G by High-Performance LC-ESI-MS/MS-SRM. Based on recent reports by
Statistical Analyses. Adduct data were obtained from 3 rats at each of 6 time points (1, 2, 5, 10, 16, and 20 weeks) . Comparisons between O 6 -methyl-G and individual adducts were carried out at each time point with the two-sample 6 -methyl-G, total POB-DNA, and total PHB-DNA adducts, involved the two-way analysis of variance with study and time as the two factors. If the interaction term between study and time was significant, then a one-way analysis of variance was carried out at each time point. The Tukey procedure was used to adjust for multiple comparisons between studies. Due to a highly skewed distribution, the adduct levels from each study were analyzed on the natural log scale.
Results
Accuracy was tested by adding various amounts of O
6 -methyl-G to 1 mg of calf thymus DNA and carrying out the analysis. The results demonstrated excellent agreement between the measured (147, 244, 504, and 1181 fmol) and added (150, 250, 500, and 1250 fmol) amounts. Precision was determined by analyzing 8 aliquots of a sample containing 500 fmol O 6 -methyl-G/mg calf thymus DNA. The coefficient of variation was 3.1%. The limit of detection was 3.0 fmol/mg DNA. Recoveries averaged 21%. A chromatogram obtained upon analysis of a DNA sample from a rat treated with NNK is illustrated in Fig. 2 . A clean peak for O 6 -methyl-G eluted 0.18 min later than that of the internal standard. O 6 -Methyl-G was not detected in lung or liver DNA from control rats.
Levels of O 6 -methyl-G in lung and liver DNA of the rats treated with NNK are summarized in Table 1 and compared with levels of the POB-DNA and PHB-DNA adducts of NNK reported previously in these tissues (Lao et al., 2007; Upadhyaya et al., 2008) . The maximal level of O 6 -methyl-G in lung DNA, 2550 Ϯ 263 fmol/mg DNA, was reached at 5 weeks and was significantly greater (P Ͻ 0.05) at that point than all other adducts except O 2 -POB-T. Levels of O 6 -methyl-G were not significantly different from those of O 2 -POB-T in weeks 1 to 5, but they were significantly less thereafter (P Ͻ 0.05). Levels of O 6 -methyl-G were not significantly different from those of 7-POB-G and O 2 -POB-C at most time points other than week 5, whereas they were significantly greater than those of O 6 -POB-dG and PHB-DNA adducts at most time points (P Ͻ 0.05). In liver, the maximal level of 7120 Ϯ 2080 fmol/mg DNA was reached after 2 weeks of treatment with NNK. O 6 -Methyl-G was the most prevalent adduct during the first 2 weeks of treatment (P Ͻ 0.03). Its mean level was similar to that of O 2 -POB-T at 5 weeks, but thereafter it rapidly declined. O 6 -POB-dG and O 6 -PHB-dG were not detected in liver DNA in the previous study.
Levels of O 6 -methyl-G are compared with those of total POB-DNA adducts and PHB-DNA adducts in Fig. 3 . The global test for difference in O 6 -methyl-G, total POB-DNA, and total PHB-DNA adduct levels across all time points was significant (P Ͻ 0.001) in both lung and liver. At each time point in lung, levels of O 6 -methyl-G were significantly lower than those of total POB-DNA adducts (P Ͻ 0.05) and greater than or comparable with total PHB-DNA adducts. In liver, the wave of O 6 -methyl-G peaked at 2 weeks, whereas that of total POB-DNA adducts peaked at 10 weeks, and levels of total PHB-DNA adducts were low throughout.
Discussion
The results of this study demonstrate that substantial amounts of the promutagenic adduct O 6 -methyl-G are produced in the lung and liver of rats treated with NNK in the drinking water for 20 weeks. Although overall O 6 -methyl-G levels were less than those of total POB-DNA adducts in lung, they were comparable with those of O 2 -POB-T, 7-POB-G, and O 2 -POB-C at several time points and were greater than those of the other DNA adducts at most time points. In liver, the initial high levels declined rapidly, undoubtedly due to recovery of the O 6 -alkylguanine-DNA-alkyltransferase (AGT) repair protein.
Previous studies have demonstrated that levels of AGT are higher in rat and mouse liver than lung, and that in mice treated with NNK, recovery of AGT occurs more rapidly in liver than in lung (Belinsky et al., 1988; Peterson et al., 2001) , which seems to be consistent with our data, because O 6 -methyl-G levels in liver declined after 2 weeks of NNK treatment, whereas in lung the decline began after 5 weeks. The two waves of DNA adducts in liver (Fig. 3B) -one for O 6 -methyl-G, peaking at 2 weeks, and the second for total POB-DNA adducts, peaking at 10 weeks-are undoubtedly due to different repair processes, with AGT not being involved in the repair of total POB-DNA adducts other than the relatively minor O 6 -POB-dG. Although the critical role of O 6 -methyl-G in A/J mouse lung tumorigenesis by NNK has been clearly shown in previous studies (Peterson and Hecht, 1991; Peterson et al., 2001) , the mechanism in rats may be more complex (Hecht, 1998) . Structure-activity studies indicate that both POB-DNA adducts and methyl-DNA adducts are important. Neither N-nitrosodimethylamine, which only methylates DNA, nor NЈ-nitrosonornicotine, which only pyridyloxobutylates DNA, is as effective as a lung carcinogen as NNK, in direct comparative experiments (Hecht, 1998) . A strong correlation of lung tumor incidence and POB-DNA adducts in the target type II cells of the rat lung has been observed over a range of NNK doses, and a similar correlation of O 6 -methyl-G and tumorigenicity was reported in Clara cells (Belinsky et al., 1990; Staretz et al., 1997) . POB-DNA adducts in type II cells and other cell types of the rat lung were diminished by treatment with 2-phenethyl isothiocyanate in tandem with a decrease in lung tumorigenicity (Staretz et al., 1997) . Taken together, the presently available data indicate that both DNA pyridyloxobutylation and methylation are important in rat lung tumorigenesis by NNK, and the results of our DNA adduct analysis, carried out at a lung carcinogenic dose of NNK given in the drinking water, support this hypothesis, because substantial amounts of both adduct types are formed. The initially high levels of O 6 -methyl-G in liver may also have an impact because a significant incidence of liver tumors was observed in rats treated with 5 ppm of NNK for 2 years (Rivenson et al., 1988) .
The miscoding properties of O 6 -methyl-G are well established (Loechler et al., 1984; Delaney and Essigmann, 2001 
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Omatch leading to G 3 A transition mutations, which have been observed in the K-ras gene isolated from tumors of mice treated with DNA-methylating agents such as NNK (Belinsky et al., 1989a; Ronai et al., 1993) . O 4 -Methyl-T induces T 3 C transition mutations,
whereas O 6 -POB-dG causes G 3 A transition and G 3 T transversion mutations (Altshuler et al., 1996; Pauly et al., 2002) . Multiple mutations due to the presence of O 2 -POB-T have been reported (Sharma et al., 2008) . Mutations have not been reported in K-ras and p53 genes isolated from rat lung tumors induced by NNK, so the relative impact of these miscoding events is unclear (Belinsky et al., 1997) .
Levels of O
6
-methyl-G in lung as measured in this study, peaking at 2550 fmol/mg DNA (Table 1) , or approximately 4.2 pmol/mol G, are quite comparable with those reported previously. Our weekly dose was approximately 3 mg/kg in the drinking water. Belinsky et al. (1990) reported 2.2 pmol/mol G in lung of rats treated with 3 mg/kg NNK weekly by subcutaneous injection for 4 weeks. Staretz et al. (1997) reported a maximum of approximately 2 pmol/mol G in lung of rats treated for 8 weeks with 5.28 mg/kg NNK per week by subcutaneous injection. Murphy et al. (1990) reported 1.1 pmol/mol G in lung of rats treated for 4 days with 0.6 mg/kg/day NNK by i.p. injection. Levels of O 6 -methyl-G in lung were considerably higher than those of either O 6 -POB-dG or O 6 -PHB-dG. There are limited data in the literature directly comparing in vitro formation of these adducts under comparable conditions and comparative rates of repair, but some studies indicate that alkylation of the O 6 position of G is favored in the reaction with methanediazohydroxide (4; Fig. 1 ) compared with POBdiazohydroxide (3; Fig. 1 ) (Peterson and Hecht, 1991) .
Multiple factors influence levels of O 6 -methyl-G in the lungs of NNK-treated rats because the different cell types have contrasting activities for NNK metabolic activation, DNA adduct formation, and AGT activity (Belinsky et al., 1988 (Belinsky et al., , 1989b (Belinsky et al., , 1990 Staretz et al., 1997) . Thus, the results reported here for whole lung are difficult to dissect with respect to these individual components. Nevertheless, the data reported here provide an important comparison of levels of the promutagenic adduct O 6 -methyl-G with those of the POB-and PHB-DNA adducts formed during chronic treatment with a lung carcinogenic dose of NNK.
